Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Enhancement of the Local CD8+ T-Cellular Immune Response to Mycobacterium tuberculosis in BCG-Primed Mice after Intranasal Administration of Influenza Vector Vaccine Carrying TB10.4 and HspX Antigens.
Vasilyev K, Shurygina AP, Zabolotnykh N, Sergeeva M, Romanovskaya-Romanko E, Pulkina A, Buzitskaya J, Dogonadze MZ, Vinogradova TI, Stukova MA. Vasilyev K, et al. Among authors: romanovskaya romanko e. Vaccines (Basel). 2021 Nov 3;9(11):1273. doi: 10.3390/vaccines9111273. Vaccines (Basel). 2021. PMID: 34835204 Free PMC article.
SARS-CoV-2 Subunit Virus-like Vaccine Demonstrates High Safety Profile and Protective Efficacy: Preclinical Study.
Vakhrusheva AV, Kudriavtsev AV, Kryuchkov NA, Deev RV, Frolova ME, Blagodatskikh KA, Djonovic M, Nedorubov AA, Odintsova E, Ivanov AV, Romanovskaya-Romanko EA, Stukova MA, Isaev AA, Krasilnikov IV. Vakhrusheva AV, et al. Among authors: romanovskaya romanko ea. Vaccines (Basel). 2022 Aug 10;10(8):1290. doi: 10.3390/vaccines10081290. Vaccines (Basel). 2022. PMID: 36016181 Free PMC article.
Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial.
Kudriavtsev AV, Vakhrusheva AV, Kryuchkov NA, Frolova ME, Blagodatskikh KA, Ivanishin TV, Djonovic M, Romanovskaya-Romanko EA, Kovalenko AN, Lioznov DA, Zubkova TG, Teplykh SV, Oseshnyuk RA, Stukova MA, Isaev AA, Krasilnikov IV. Kudriavtsev AV, et al. Among authors: romanovskaya romanko ea. Vaccines (Basel). 2023 Feb 1;11(2):326. doi: 10.3390/vaccines11020326. Vaccines (Basel). 2023. PMID: 36851204 Free PMC article.
Longitudinal Analysis of Neuraminidase and Hemagglutinin Antibodies to Influenza A Viruses after Immunization with Seasonal Inactivated Influenza Vaccines.
Sergeeva MV, Romanovskaya-Romanko EA, Krivitskaya VZ, Kudar PA, Petkova NN, Kudria KS, Lioznov DA, Stukova MA, Desheva YA. Sergeeva MV, et al. Among authors: romanovskaya romanko ea. Vaccines (Basel). 2023 Nov 20;11(11):1731. doi: 10.3390/vaccines11111731. Vaccines (Basel). 2023. PMID: 38006063 Free PMC article.
Hybrid Proteins with Short Conformational Epitopes of the Receptor-Binding Domain of SARS-CoV-2 Spike Protein Promote Production of Virus-Neutralizing Antibodies When Used for Immunization.
Karyagina AS, Gromov AV, Grunina TM, Lyaschuk AM, Poponova MS, Kleymenov DA, Strukova NV, Generalova MS, Ryazanova AV, Galushkina ZM, Dobrynina OY, Bolshakova TN, Sergeeva MV, Romanovskaya-Romanko EA, Krasilnikov IV, Subbotina ME, Lunin VG. Karyagina AS, et al. Among authors: romanovskaya romanko ea. Biochemistry (Mosc). 2022 Apr;87(4):319-330. doi: 10.1134/S0006297922040022. Biochemistry (Mosc). 2022. PMID: 35527370 Free PMC article.
20 results